199 related articles for article (PubMed ID: 30097413)
1. First results from the Swedish National Pancreatic and Periampullary Cancer Registry.
Tingstedt B; Andersson B; Jönsson C; Formichov V; Bratlie SO; Öhman M; Karlsson BM; Ansorge C; Segersvärd R; Gasslander T
HPB (Oxford); 2019 Jan; 21(1):34-42. PubMed ID: 30097413
[TBL] [Abstract][Full Text] [Related]
2. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
[TBL] [Abstract][Full Text] [Related]
3. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
Tsao JI; Rossi RL; Lowell JA
Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
[TBL] [Abstract][Full Text] [Related]
4. Tumour origin, diagnostic accuracy and histopathological evaluation in patients with periampullary cancer: nationwide cohort study.
Byrling J; Ghazi S; Andersson B
BJS Open; 2023 Sep; 7(5):. PubMed ID: 37864577
[TBL] [Abstract][Full Text] [Related]
5. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
[TBL] [Abstract][Full Text] [Related]
6. Pancreaticoduodenectomy for periampullary cancer: does the tumour entity influence perioperative morbidity and long-term outcome?
Wiltberger G; Krenzien F; Atanasov G; Hau HM; Schmelzle M; Bartels M; Benzing C
Acta Chir Belg; 2018 Dec; 118(6):341-347. PubMed ID: 30203717
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary Carcinomas.
Schmuck RB; Brokat C; Andreou A; Felsenstein M; Klein F; Sinn B; Pratschke J; Bahra M
Anticancer Res; 2018 Sep; 38(9):5379-5386. PubMed ID: 30194192
[TBL] [Abstract][Full Text] [Related]
8. Periampullary adenocarcinoma: analysis of 5-year survivors.
Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
[TBL] [Abstract][Full Text] [Related]
9. Is pancreatoduodenectomy justified for periampullary cancers with regional lymph node involvement?
Shyr YM; Su CH; Lo SS; Wang HC; Lui WY
Am Surg; 1995 Apr; 61(4):288-93. PubMed ID: 7893088
[TBL] [Abstract][Full Text] [Related]
10. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
Schmocker RK; Wright MJ; Ding D; Javed AA; Cameron JL; Lafaro K; Burns WR; He J; Wolfgang CL; Burkhart RA
J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
[TBL] [Abstract][Full Text] [Related]
11. Reoperative surgery for periampullary adenocarcinoma.
McGuire GE; Pitt HA; Lillemoe KD; Niederhuber JE; Yeo CJ; Cameron JL
Arch Surg; 1991 Oct; 126(10):1205-10; discussion 1210-2. PubMed ID: 1681794
[TBL] [Abstract][Full Text] [Related]
12. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
13. [The curative surgery of periampullary tumors. The results of 48 resections].
de Almeida JC; Bettencourt A; Costa CS; de Almeida JM
Acta Med Port; 1995 Jun; 8 Suppl 1():S35-9. PubMed ID: 7653304
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information.
Hugenschmidt H; Labori KJ; Brunborg C; Verbeke CS; Seeberg LT; Bendigtsen Schirmer C; Renolen A; Borgen E; Naume B; Wiedswang G
BMC Cancer; 2020 Nov; 20(1):1107. PubMed ID: 33198661
[TBL] [Abstract][Full Text] [Related]
15. Volume-outcome relationships in pancreatoduodenectomy for cancer.
van der Geest LG; van Rijssen LB; Molenaar IQ; de Hingh IH; Groot Koerkamp B; Busch OR; Lemmens VE; Besselink MG;
HPB (Oxford); 2016 Apr; 18(4):317-24. PubMed ID: 27037200
[TBL] [Abstract][Full Text] [Related]
16. Underutilization of Surgery in Periampullary Cancer Treatment.
Michalski CW; Liu B; Heckler M; Roth S; Sun H; Heger U; Büchler MW; Hackert T
J Gastrointest Surg; 2019 May; 23(5):959-965. PubMed ID: 30088190
[TBL] [Abstract][Full Text] [Related]
17. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
[TBL] [Abstract][Full Text] [Related]
18. Periampullary tumors: which ones should be resected?
Jones BA; Langer B; Taylor BR; Girotti M
Am J Surg; 1985 Jan; 149(1):46-52. PubMed ID: 3966641
[TBL] [Abstract][Full Text] [Related]
19. [Surgical therapy of pancreatic and periampullary carcinoma in elderly patients].
Benhidjeb T; Zanow J
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():489-91. PubMed ID: 9101908
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and therapeutic dilemmas in periampullary lesions.
Tsai PJ; Wang SE; Shyr YM; Chen TH; Su CH; Wu CW
Hepatogastroenterology; 2012; 59(117):1621-5. PubMed ID: 22683981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]